Moreover, considering that anxiety plays an important fact in migraine risk, detecting anxiety symptoms and implementing pharmacological and not treatments targeting Nrf-2/NF-κB pathway could improve headache control and patient’s quality of life. Here, NFE2L2 is linked to migraine disorder.